Marksans Pharma Limited
Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products.
What Marksans files
- Others46
- Updates43
- Investor Meet28
- Important12
- Board Meeting12
- PPTs7
Marksans Pharma Limited has informed the Exchange about Copy of Newspaper Publication regarding transfer of unclaimed dividend and equity shares of the Company to the IEPF
Marksans Pharma will participate in a physical group meet at the Ashwamedh - Elara India Dialogue 2026 on September 02, 2026, at Hyatt, Santacruz East, Mumbai. The company confirmed that no unpublished price sensitive information will be shared during the interactions.
Marksans Pharma Limited has submitted the Exchange a copy Srutinizers report along with voting result of Annual General Meeting held on August 27, 2026.
Marksans Pharma Limited has informed the Exchange regarding Proceedings of 34th Annual General Meeting held on August 27, 2026
Marksans Pharma received an ESG score of 56 from Crisil ESG Ratings & Analytics for Fiscal 2026. This score reflects the company's environmental, social, and governance performance based on public data.